Literature DB >> 8908396

Insulin-induced lipoatrophy in type I diabetes. A possible tumor necrosis factor-alpha-mediated dedifferentiation of adipocytes.

C Atlan-Gepner1, P Bongrand, C Farnarier, L Xerri, R Choux, J F Gauthier, T Brue, P Vague, J J Grob, B Vialettes.   

Abstract

OBJECTIVE: To test the hypothesis that tumor necrosis factor (TNF)-alpha may mediate the loss and the dedifferentiation of subcutaneous fat tissue in the insulin-induced lipoatrophies of a diabetic patient who presented extensive lesions. RESEARCH DESIGN AND METHODS: An in vitro exploration of cytokine production by peripheral blood mononuclear cells (PBMC) from the reported case was performed and compared with the same explorations of PBMC from three nondiabetic subjects and three diabetic patients without lipoatrophic lesions. A proliferation test and an evaluation of TNF-alpha and interleukin (IL)-6 production from PBMC in presence of insulin were studied.
RESULTS: The production of TNF-alpha and IL-6 by the macrophages of the patient in presence of insulin were dramatically increased in comparison with control subjects. This process needed cooperation with other lymphoid cells and was abrogated by dexamethasone.
CONCLUSIONS: In our reported case, a local hyperproduction of TNF-alpha from macrophages that was induced by the injected insulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8908396     DOI: 10.2337/diacare.19.11.1283

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

Review 1.  Proteomic Changes to the Updated Discovery of Engineered Insulin and Its Analogs: Pros and Cons.

Authors:  Naeema Hanif; Hezhou Wu; Peizhou Xu; Yun Li; Amir Bibi; Asma Zulfiqar; Muhammad Zafar Iqbal; Muhammad Tahir; Xiangyang Zhang; Asif Ali
Journal:  Curr Issues Mol Biol       Date:  2022-02-11       Impact factor: 2.976

2.  Focal lipoatrophy of face: a rare esthetic complaint.

Authors:  K Anbarasi; S Sathasivasubramanian; C L Krithika; P M Venkatasai
Journal:  J Clin Imaging Sci       Date:  2012-03-22

3.  Lipoatrophy in a girl with type 1 diabetes: beneficial effects of treatment with a glucocorticoid added to an insulin analog.

Authors:  Hester T Swelheim; Ciska Westerlaken; Evelyn van Pinxteren-Nagler; Gianni Bocca
Journal:  Diabetes Care       Date:  2012-03       Impact factor: 19.112

4.  Detemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new case.

Authors:  Sima Saberi; Nazanene H Esfandiari; Mark P MacEachern; Meng H Tan
Journal:  Clin Diabetes Endocrinol       Date:  2015-10-15

5.  Machine Learning Decision Support for Detecting Lipohypertrophy With Bedside Ultrasound: Proof-of-Concept Study.

Authors:  Ela Bandari; Tomas Beuzen; Lara Habashy; Javairia Raza; Xudong Yang; Jordanna Kapeluto; Graydon Meneilly; Kenneth Madden
Journal:  JMIR Form Res       Date:  2022-05-06

6.  Concurrence of Lipoatrophy and Lipohypertrophy in Children With Type 1 Diabetes Using Recombinant Human Insulin: Two Case Reports.

Authors:  Arijit Singha; Rana Bhattarcharjee; Sujoy Ghosh; Sumit Kumar Chakrabarti; Arjun Baidya; Subhankar Chowdhury
Journal:  Clin Diabetes       Date:  2016-01

7.  Unilateral Limb Thinning -Thinking Out of the Box.

Authors:  Chandramouleeswaran Venkatraman; Shubha Subramanian; Daniel Sweetson Abraham; Kannan Vellaichamy
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.